RedHill Biopharma Ltd. (RDHL)

RedHill Biopharma Revenue

RedHill Biopharma had revenue of $2.04M in the half year ending June 30, 2025, with 58.59% growth. This brings the company's revenue in the last twelve months to $9.55M, up 157.62% year-over-year. In the year 2024, RedHill Biopharma had annual revenue of $8.04M with 23.17% growth.

• Revenue (ttm): $9.55M
• Revenue Growth: +157.62%
• P/S Ratio: 0.19
• Revenue / Employee: $272,857
• Employees: 35
• Market Cap: 3.99M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.04M	1.51M	23.17%
Dec 31, 2023	6.53M	-55.27M	-89.43%
Dec 31, 2022	61.80M	-23.96M	-27.94%
Dec 31, 2021	85.76M	21.40M	33.25%
Dec 31, 2020	64.36M	58.07M	923.03%
Dec 31, 2019	6.29M	-2.07M	-24.75%
Dec 31, 2018	8.36M	4.35M	108.63%
Dec 31, 2017	4.01M	3.91M	3,867.33%
Dec 31, 2016	101.00K	98.00K	3,266.67%
Dec 31, 2015	3.00K	-7.01M	-99.96%
Dec 31, 2014	7.01M	7.00M	58,350.00%
Dec 31, 2013	12.00K	-4.00K	-25.00%
Dec 31, 2012	16.00K	-7.00K	-30.43%
Dec 31, 2011	23.00K	-	-
Dec 31, 2010	-	-	-